Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120550703 | 12055070 | 3 | F | 20100818 | 20160801 | 20160209 | 20160810 | EXP | US-BAYER-2016-022657 | BAYER | 61.00 | YR | A | F | Y | 58.96000 | KG | 20160810 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120550703 | 12055070 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | 400 MG, UNK | 21085 | 400 | MG | FILM-COATED TABLET | |||||||
| 120550703 | 12055070 | 2 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | TABLET | |||||||
| 120550703 | 12055070 | 3 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | TABLET | |||||||
| 120550703 | 12055070 | 4 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | TABLET | |||||||
| 120550703 | 12055070 | 5 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 120550703 | 12055070 | 6 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | ||||||||
| 120550703 | 12055070 | 7 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 400 MG/D, 5IW | 0 | SOLUTION FOR INFUSION | ||||||||||
| 120550703 | 12055070 | 8 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 120550703 | 12055070 | 9 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 120550703 | 12055070 | 10 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 120550703 | 12055070 | 11 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 120550703 | 12055070 | 12 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 120550703 | 12055070 | 13 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | 2.5 MG/ML, UNK | 0 | |||||||||||
| 120550703 | 12055070 | 14 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 12.5 MG, UNK | 0 | 12.5 | MG | |||||||||
| 120550703 | 12055070 | 15 | C | LOVASTATIN. | LOVASTATIN | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 120550703 | 12055070 | 16 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120550703 | 12055070 | 8 | Blood pressure measurement |
| 120550703 | 12055070 | 10 | Ulcer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120550703 | 12055070 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120550703 | 12055070 | Cardiovascular disorder | |
| 120550703 | 12055070 | Mental disorder | |
| 120550703 | 12055070 | Musculoskeletal injury | |
| 120550703 | 12055070 | Nervous system disorder | |
| 120550703 | 12055070 | Neuropathy peripheral | |
| 120550703 | 12055070 | Pain | |
| 120550703 | 12055070 | Peripheral nerve injury | |
| 120550703 | 12055070 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120550703 | 12055070 | 1 | 20100818 | 0 | ||
| 120550703 | 12055070 | 2 | 20010829 | 0 | ||
| 120550703 | 12055070 | 3 | 20020307 | 0 | ||
| 120550703 | 12055070 | 4 | 20030612 | 0 | ||
| 120550703 | 12055070 | 5 | 20090218 | 20090224 | 0 | |
| 120550703 | 12055070 | 6 | 20100920 | 0 | ||
| 120550703 | 12055070 | 7 | 20090908 | 20090913 | 0 |